m+Medelevator.RU
← Поиск публикаций
Journal of the National Comprehensive Cancer Network : JNCCN · 2026

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Abu-Rustum Nadeem R, Campos Susana M, Amarnath Sudha, Arend Rebecca, Barber Emma, Bradley Kristin, Brooks Rebecca, Chino Junzo, Chon Hye Sook, Crispens Marta Ann, Damast Shari, Fisher Christine M, Frederick Peter, Gaffney David K, Gaillard Stephanie, Giuntoli Robert, Glaser Gretchen, Glaser Scott, Howitt Brooke E, Kendra Kari, Landrum Lisa, Lea Jayanthi, Lee Nita, Mantia-Smaldone Gina, Mariani Andrea, Mutch David, Nagel Christa, Nekhlyudov Larissa, Nwachukwu Chika, Podoll Mirna, Rodabaugh Kerry, Salani Ritu, Schorge John, Schuetze Scott, Siedel Jean, Soliman Pamela, Ueda Stefanie, Urban Renata, Wyse Emily, McMillian Nicole, Sambandam Vaishnavi

Аннотация

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Vaginal Cancer outline the recommended diagnostic workup, staging considerations, and treatment options for this rare malignancy. Because vaginal cancer is uncommon and shares many biologic and clinical characteristics with cervical cancer, several management recommendations, particularly systemic therapy, are extrapolated from evidence and practices established for cervical cancer. This guideline excerpt summarizes key components of management, including diagnostic evaluation and workup, principles of staging, pathology considerations, radiation therapy principles, and primary treatment recommendations for both early-stage and advanced disease. It also details approaches to manage relapses, including locoregional recurrence and distant metastases, and provides an in-depth overview of systemic therapy recommendations for vaginal cancer.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты